China NT Pharma Group Company Limited

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Rok finansowy 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 2,668 2,758 739 754 865 848 915 605 572 366 222 227 207 7 38
Przychód Δ r/r 0.0% 3.4% -73.2% 2.0% 14.7% -2.0% 7.9% -33.9% -5.5% -36.0% -39.4% 2.2% -8.6% -96.4% 415.3%
Marża brutto 24.9% 32.3% 36.8% 38.3% 45.3% 53.3% 53.9% 80.1% 73.8% 71.3% 60.8% 64.2% 60.5% 100.0% 13.9%
EBIT (mln) 256 366 -1,117 -578 96 136 186 270 -247 -22 -68 -59 18 -56 -13
EBIT Δ r/r 0.0% 43.1% -405.6% -48.3% -116.6% 41.5% 36.6% 45.2% -191.5% -91.1% 209.0% -13.0% -131.1% -404.9% -76.5%
EBIT (%) 9.6% 13.3% -151.1% -76.6% 11.1% 16.0% 20.3% 44.6% -43.1% -6.0% -30.7% -26.1% 8.9% -763.1% -34.8%
Koszty finansowe (mln) 45 58 52 70 78 27 28 43 80 103 85 89 72 29 0
EBITDA (mln) 273 390 -420 -131 90 171 213 312 -211 9 -44 -17 40 1 -9
EBITDA(%) 10.2% 14.1% -56.8% -17.4% 10.4% 20.2% 23.3% 51.5% -36.9% 2.5% -19.7% -7.5% 19.1% 18.1% -22.8%
Podatek (mln) 81 73 -68 21 15 13 41 16 40 10 -9 3 12 0 0
Zysk Netto (mln) 129 234 -1,109 -673 2 88 116 165 -958 -593 -191 -151 -66 -144 -53
Zysk netto Δ r/r 0.0% 82.2% -573.3% -39.3% -100.3% 4101.9% 32.5% 42.2% -679.7% -38.1% -67.8% -20.9% -56.1% 116.2% -62.8%
Zysk netto (%) 4.8% 8.5% -150.1% -89.3% 0.2% 10.3% 12.7% 27.3% -167.6% -162.1% -86.3% -66.8% -32.1% -1949.4% -140.6%
EPS 0.16 0.23 -1.03 -0.62 0.0019 0.0619 0.075 0.11 -0.61 -0.34 -0.1 -0.0801 -0.035 -0.17 -0.2
EPS (rozwodnione) 0.16 0.23 -1.03 -0.62 0.0019 0.0614 0.0746 0.0912 -0.61 -0.34 -0.1 -0.0801 -0.035 -0.73 -0.2
Ilośc akcji (mln) 811 1,001 1,082 1,082 1,082 1,417 1,548 1,712 1,566 1,764 1,887 1,890 1,899 848 264
Ważona ilośc akcji (mln) 816 1,009 1,082 1,082 1,082 1,428 1,557 1,712 1,566 1,764 1,887 1,890 1,899 198 264
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY